http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-944197-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-90 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-60 |
| filingDate | 1994-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed3568f2cd7f1da249f10327e7214abd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a05d1759e305c46fcd3bb3d9f94617c |
| publicationDate | 1995-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NO-944197-L |
| titleOfInvention | Moenomycin cleavage products with hydroxylated and oxidized lipid side chain |
| abstract | MUST with hydroxylated or oxidized lipid side chains and Moenomycline analogs, process for preparation and use of these compounds are described. MUST have the formula I C atom bearing the sub-R 1, R 2, R 4 and R 5 independently of one another is a hydrocyl group or hydrogen and R 3 means hydrogen, in that the bond between the substituent R 4 and the C atom of which the substituent R 5 is a single bond, or R1 and R2 are independently a hydroxyl group or hydrogen and R3 is hydrogen, in that the bond between the substituent R4 and the C atom of which the substituent R5 is a double bond or R1, R2 and R5 are independently a group or hydrogen and R 3 and R 4 are together an oxo group. MUST be hydroxylated and oxidized by the microorganism of the genus Cryptococcus in the lipid chain and in this form is a starting compound for the preparation of Moenomycin analogues which can be used as a drug. The monoenomycin analogs have the following chemical structure, the C atom, which carries the sub-hydroxyl-11 NHAc wherein R 1 to R 5 have the above meaning. |
| priorityDate | 1993-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.